Investor Relations
Committed to our shareholders.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put IntriCon Corporation's financial performance into perspective.
Recent Releases
Nov 17, 2011
IntriCon Receives FDA 510(k) Marketing Clearance for Sirona Cardiac Diagnostic Monitor
Nov 8, 2011
IntriCon Reports 2011 Third-Quarter Results
Stock Information
| NASDAQ:IIN
$6.90 - 0.09 |
Jan 27, 2012
3:41 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
Fact Sheets
Corporate Fact SheetFinancial Tear Sheet
ANNUAL REPORTS
2010 Annual Report2009 Annual Report
2008 Annual Report
2007 Annual Report
2006 Annual Report
CONFERENCE CALL TRANSCRIPTS
2011 Third-Quarter Results2011 Second-Quarter Results
2011 First-Quarter Results
2010 Fourth-Quarter Results
2010 Third-Quarter Results
2010 Second-Quarter Results
2010 First-Quarter Results
2009 Fourth-Quarter Results
2009 Third-Quarter Results
2009 Second-Quarter Results